Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Jean-Francedillaois Lavall Ee
Introduction
Jean-Francedillaois Lavall Ee is a notable inventor based in Laval, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, his work has the potential to impact cancer treatment significantly.
Latest Patents
Lavall Ee's latest patents include "Processes Antineoplastic Heteronaphthoquinones" and "Heterocyclic Anthracycline Analogs." The first patent relates to naphthoquinone derivatives, detailing processes and intermediates for preparing these derivatives. It also discusses pharmaceutical compositions and their use as antitumor agents in mammals. The second patent describes novel pyrano heterocyclic anthracycline derivatives, which are useful in treating various cancers, including breast cancer, leukemia, and melanoma. These compounds may also be utilized ex vivo for treating cancerous bone marrow before retransplantation.
Career Highlights
Lavall Ee is associated with Biochem Pharma Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new compounds that can provide effective treatments for cancer patients.
Collaborations
He has collaborated with notable coworkers, including Giorgio Attardo and Marc Courchesne, contributing to the advancement of cancer treatment through innovative research.
Conclusion
Jean-Francedillaois Lavall Ee's contributions to pharmaceutical innovations highlight his commitment to improving cancer treatment. His patents reflect a dedication to developing effective therapies that can make a difference in patients' lives.